<body><a name="drugname"></a><table class="topbox" width="100%">
<tr>
<td><span class="topboxgenname">CEPHALEXIN</span><br/>(sef-a-lex'in)<br/><span class="topboxtradename">Cefanex, </span><span class="topboxtradename">Ceporex_A, </span><span class="topboxtradename">Keflet, </span><span class="topboxtradename">Keflex, </span><span class="topboxtradename">Keftab, </span><span class="topboxtradename">Novolexin_A<br/></span><b>Classifications:</b> <span class="classification">antiinfective</span>; <span class="classification">antibiotic</span>; <span class="classification">first-generation cephalosporin</span><br/><b>Prototype: </b>Cefazolin<br/><b>Pregnancy Category: </b>B<br/></td>
</tr>
</table>
<h1><a name="avail">Availability</a></h1>
<p>250 mg, 500 mg capsules; 250 mg, 500 mg, 1 g tablets; 125 mg/5 mL, 250 mg/5 mL suspension</p>
<h1><a name="action">Actions</a></h1>
<p>Semisynthetic derivative of cephalosporin C. Broad-spectrum, first-generation cephalosporin antibiotic with antiinfective
         activity similar to that of cefazolin but reportedly less potent. Preferentially binds to one or more of the penicillin-binding
         proteins (PBP) located on cell walls of susceptible organisms. This inhibits third and final stage of bacterial cell wall
         synthesis, thus killing the bacterium. Ineffective against many gram-negative or anaerobic organisms. Cross-allergenicity
         between cephalosporins and penicillins has been reported.
      </p>
<h1><a name="therapef">Therapeutic Effects</a></h1>
<p>It is active against many gram-positive aerobic cocci and much less active against gram-negative bacteria. Effectively treats
         osteomyelitis, otitis media, streptococcal pharyngitis, prostate and respiratory infections, skin and urinary tract infections,
         eliminating or reducing infection.
      </p>
<h1><a name="uses">Uses</a></h1>
<p>To treat infections caused by susceptible pathogens in respiratory and urinary tracts, middle ear, skin, soft tissue, and
         bone.
      </p>
<h1><a name="contrain">Contraindications</a></h1>
<p>Hypersensitivity to cephalosporins and related antibiotics; pregnancy (category B), lactation. Safe use in infants 
      </p><h1><a name="precaution">Cautious Use</a></h1>
<p>History of hypersensitivity to penicillin or other drug allergy; severely impaired renal function.</p>
<h1><a name="rtedsg">Route &amp; Dosage</a></h1>
<table cellpadding="4" cellspacing="0" class="rdbox" width="100%">
<tr>
<td><span class="indicationtitle">Mild to Moderate Infection</span><br/><span class="rdage">Adult:</span> <span class="rdroute">PO</span> 250500 mg q6h<br/><span class="rdage">Child:</span> <span class="rdroute">PO</span> 25100 mg/kg/d in 4 divided doses<br/><br/><span class="indicationtitle">Skin and Skin Structure Infections</span><br/><span class="rdage">Adult:</span> <span class="rdroute">PO</span> 500 mg q12h<br/><br/><span class="indicationtitle">Otitis Media</span><br/><span class="rdage">Child:</span> <span class="rdroute">PO</span> 75100 mg/kg/d in 4 divided doses<br/></td>
</tr>
</table>
<h1><a name="admintn">Administration</a></h1><span class="adminroutetype">Oral</span><br/><ul>
<li>Cephalexin oral suspension should be refrigerated; discard unused portions 14 d after preparation. Label should indicate expiration
            date. Keep tightly covered. Shake suspension well before pouring.
         </li>
</ul>
<h1><a name="adverse">Adverse Effects (<img src="../images/special/greaterorequal.gif"/>1%)</a></h1><span class="typehead"> Body as a Whole:</span> Angioedema, <span class="speceff-life">anaphylaxis</span>, superinfections. <span class="typehead">GI:</span>
<span class="speceff-common">Diarrhea</span> (generally mild), nausea, vomiting, anorexia, abdominal pain. <span class="typehead">CNS:</span> Dizziness, headache, fatigue. <span class="typehead">Skin:</span> Rash, urticaria. 
      <h1><a name="dtintefer">Diagnostic Test Interference</a></h1>
<p>False-positive <span class="alt">urine glucose</span> determinations using <span class="alt">copper sulfate reagents,</span> e.g., <span class="alt">Clinitest,</span>
<span class="alt">Benedict's reagent,</span> but not with <span class="alt">glucose oxidase (enzymatic) tests,</span> e.g., <span class="alt">Tes-Tape,</span>
<span class="alt">Diastix,</span>
<span class="alt">Clinistix.</span> Positive <span class="alt">direct Coombs' test</span> may complicate transfusion <span class="alt">cross-matching procedures</span> and <span class="alt">hematologic studies.</span>
</p>
<h1><a name="interactions">Interactions</a></h1><span class="typehead">Drug:</span>
<b>Probenecid</b> decreases renal elimination of cephalexin. 
      <h1><a name="pharmaks">Pharmacokinetics</a></h1><span class="typehead">Absorption:</span> rapidly absorbed from GI tract; stable in stomach acid. <span class="typehead">Peak:</span> 1 h. <span class="typehead">Distribution:</span> Widely distributed in body fluids with highest concentration in kidney; crosses placenta. <span class="typehead">Elimination:</span> 80100% eliminated unchanged in urine in 8 h; excreted in breast milk. <span class="typehead">Half-Life:</span> 3870 min. 
      <h1><a name="nursing"><span class="implictitle">Nursing Implications</span></a></h1>
<p><span class="adeffecttitle">Assessment &amp; Drug Effects</span></p>
<ul>
<li>Determine history of hypersensitivity reactions to cephalosporins and penicillin and history of other drug allergies before
            therapy is initiated.
         </li>
<li>Lab tests: Evaluate renal and hepatic function periodically in patients receiving prolonged therapy.</li>
<li>Monitor for manifestations of hypersensitivity (see Signs &amp; Symptoms, Appendix F). Discontinue drug and report their appearance
            promptly.
         </li>
</ul>
<p><span class="eductitle">Patient &amp; Family Education</span></p>
<ul>
<li>Take medication for the full course of therapy as directed by physician.</li>
<li>Keep physician informed if adverse reactions appear.</li>
<li>Be alert to S&amp;S of superinfections (see Appendix F). These symptoms should be reported promptly and appropriate therapy instituted.</li>
<li>Do not breast feed while taking this drug.</li>
</ul>
<hr/>
<p><span class="footer">Common adverse effects in <i>italic</i>, life-threatening effects <u>underlined</u>; generic names in <b>bold</b>; classifications in <small>SMALL CAPS</small>; <img border="0" src="../images/maple.gif"/> Canadian drug name; <img border="0" src="../images/pr.gif"/> Prototype drug</span></p>
</body>